An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis
Recruiting now
Conditions studied: Ulcerative Colitis (UC)
In brief
A study to assess the safety and effectiveness of Velsipity Tablets 2 mg during long-term treatment (up to a maximum of 52 weeks) in patients with ulcerative colitis under actual medical practice.
Key facts
- Study ID
- NCT07459686
- Run by
- Pfizer
- People needed
- 553
- Starts
- 2026-04-27
- Expected to finish
- 2029-01-29
- Last updated by the study team
- 2026-05-18
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pfizer — Tokyo, Japan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.